Releases
Cardiol Therapeutics Shareholders Confirm Board in Annual Vote
Shareholders of Cardiol Therapeutics backed the company’s management team during its annual general meeting held via live audio webcast on June 24. Investors approved all proposed resolutions, including the appointment of auditors and the reelection of the board of directors, signaling continued support for the firm's clinical development strategy.





















.jpg?disable=upscale&width=1200&height=630&fit=crop)

